Market Overview

UPDATE: Citigroup Reiterates Hanesbrands at Buy Ahead of Q4 Results

Share:
Related HBI
Earnings Scheduled For May 2, 2017
Barron's Picks And Pans: Drug Stocks, Hanesbrands, Wabtec And More

Citigroup maintained Hanesbrands (NYSE: HBI) with a Buy rating and a $48 price target.

Citigroup noted, "HBI reports 4Q12 EPS on 02/05/13 (AMC). We are expecting $1.07 versus the street at $0.98. HBI guided 4Q12 EPS to $1.00-$1.06. HBI's 2012 EPS guidance is $2.54-$2.60 vs. our estimate of $2.63 and consensus of $2.53. We believe investors will focus on 2013 expectations and guidance, pricing expectations, unit growth, market share gains, the cotton windfall in 2013, acquisitions, and capital allocation. We reiterate our Buy (1) rating on HBI."

Hanesbrands closed at $37.74 on Friday.

Latest Ratings for HBI

DateFirmActionFromTo
Mar 2017Goldman SachsInitiates Coverage OnNeutral
Feb 2017Morgan StanleyDowngradesOverweightEqual-Weight
Dec 2016CL KingUpgradesNeutralBuy

View More Analyst Ratings for HBI
View the Latest Analyst Ratings

Posted-In: CitigroupAnalyst Color Reiteration Analyst Ratings

 

Related Articles (HBI)

View Comments and Join the Discussion!